Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Jumper who wrote (2122)	1/30/2000 10:50:00 PM
From: Mike M	Read Replies (1) \| Respond to of 5582

Much like your analysis on this particular equity. Oh oh....Too many words for you to try to come up with a coherent thought. Better stick to you modus operandi, two or three words...max!

To: Jumper who wrote (2122)	1/30/2000 10:52:00 PM
From: DanZ	Read Replies (1) \| Respond to of 5582

<Much like your analysis on this particular equity.> Ok, here's some analysis. Sales up 84% YTY in the first three quarters of 99. Sales estimated to be up ~450% YTY in the fourth quarter 99. Sales estimated to be up ~300% sequentially from the third quarter 99 to fourth quarter 99. Gross margins much improved in Q3 99 and will improve even more in Q4 99. The company will most likely report their first profit in Q4 99 after 15 consecutive quarterly losses, and the profit in the first quarter 00 will accelerate (my estimate). Sales in the first quarter 00 are estimated to be up ~125% sequentially from Q4 99 and 1100% from Q4 99. Nicotine gum products with joint venture partner Swedish Match will likely produce revenues and profits beginning in the third quarter 00 and accelerate in 2001. A dental gum agreement with a company such as Procter & Gamble or Colgate is nearing finalization (my estimate). The independent clinical studies that will prove that Zicam reduces the duration and severity of the common cold and prevents the common cold will be released any day (my speculation on the results and timing). Earnings of $2.05 likely this year (my estimate). Institutional ownership has increased four quarters in a row and appears to be picking up steam the last month. What part of this analysis do you fail to understand? Me and others that you characterize as "clowns" and "criminals" have been long this stock since 9 to 10 for about a year. We've seen bozos like you come and go after trying every short trick in the book. The scare tactics, 3 minutes of DD LMAO, lies, misrepresentations, and plain stupidity don't phase me because I have a lot of DD under my belt and know where this company is going with great confidence. Good luck scalping a buck or two on your short sale. You'll be lucky to get it, and I believe that investors who stay long GUMM will make much more money with less risk than short sellers. Shorts are fighting bullish fundamentals; they are fighting the trend in the stock; now they are fighting institutions buying in. Regards, Dan